欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Proteasome/Ubiquitin-Heat Shock Protein (HSP)-SNX-2112
SNX-2112

Chemical Structure : SNX-2112

CAS No.: 908112-43-6

SNX-2112 (PF-04928473, SNX2112)

货号: PC-62491Not For Human Use, Lab Use Only.

SNX-2112 (PF-04928473) is a potent, selective Hsp90 inhibitor with binding IC50 of 30 nM for both HSP90α and HSP90β.

规格 价格 库存 数量
5 mg ¥1480 In stock
10 mg ¥2380 In stock
25 mg ¥3880 In stock
50 mg Get quote
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

SNX-2112 (PF-04928473) is a potent, selective Hsp90 inhibitor with binding IC50 of 30 nM for both HSP90α and HSP90β.
SNX-2112 shows weak affinity for Hsp90 family members Grp94 and Trap-1 (IC50=0.8-4.2 uM).
SNX-2112 has properties and potency, including degradation of HER2, mutant EGFR, and other client proteins, inhibition of ERK and Akt activation, and induction of a Rb-dependent G1 arrest with subsequent apoptosis.
SNX-2112 is the orally bioavailbe prodrug SNX-5422, inhibits MM cell growth and prolongs survival in a xenograft murine model.

物理化学性质&存储条件

分子量 464.489
分子式 C23H27F3N4O3
外观性状 Solid
CAS No.
储存条件
固体粉末
-20 °C 12 个月; 4°C 6 个月
配置液
-80 °C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

4-(6,6-Dimethyl-4-oxo-3-trifluoromethyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(trans-4-hydroxy-cyclohexylamino)-benzamide

参考文献

1. Okawa Y, et al. Blood. 2009 Jan 22;113(4):846-55.

2. Chandarlapaty S, et al. Clin Cancer Res. 2008 Jan 1;14(1):240-8.

3. Bachleitner-Hofmann T, et al. Clin Cancer Res. 2011 Jan 1;17(1):122-33.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: